Literature DB >> 3586569

[Correlation of "latent hyperthyroidism" with psychological and somatic changes].

M Röckel, J Teuber, R Schmidt, S Kaumeier, H Häfner, K H Usadel.   

Abstract

The study reported here was undertaken to establish the degree to which a person in a preclinical state of hyperthyroidism, with (by definition) euthyroid T3 and T4 levels but suppressed TRH on testing, already exhibits psychological changes and clinical symptoms. Two groups of 20 patients each, with clear clinical and preclinical hyperthyroidism (as defined by laboratory parameters), were studied, as well as a group of 20 controls. The subjects' psychological state of mind was investigated using self-rating scales, including the state-trait-anxiety inventory (STAI), "Befindlichkeits"-Skala (Bf-S'), depression scale (D-S'), and a list of adjectives (EWL-K) with 14 different aspects of affective moods. Cognitive achievements were evaluated using the d2 test. Subjects were examined for somatic symptoms in accordance with Crooks' index of hyperthyroidism. The results clearly showed that typical psychological and somatic changes are already present in preclinical hyperthyroidism, these changes being partly identical with those of definite hyperthyroidism. In both patient groups, a significant increase in anxiety, a sense of not feeling well, and emotional irritability were found, as well as a tendency towards depressiveness, and an increased lack of vitality and activity. Attentiveness and concentration in both patient groups were lower than in the control group. Both patient groups showed the same prevalence of symptoms, such as palpitations, preference of cold over heat, excessive sweating, nervousness, fine digital tremor, and increased heart rate. With regard to the results, the diagnosis "preclinical hyperthyroidism" thus gains importance. Further prospective studies are required to answer the question whether antithyroidal treatment will influence the described psychological and somatic state of patients with preclinical hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3586569     DOI: 10.1007/bf01773447

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  19 in total

1.  Statistical methods applied to the clinical diagnosis of thyrotoxicosis.

Authors:  J CROOKS; I P MURRAY; E J WAYNE
Journal:  Q J Med       Date:  1959-04

2.  Autonomy in euthyroid goitre: maladaptation to iodine deficiency.

Authors:  D Emrich; M Bähre
Journal:  Clin Endocrinol (Oxf)       Date:  1978-03       Impact factor: 3.478

3.  [Neuroendocrinologic and endocrinologic research in depressive patients].

Authors:  F Holsboer; O Benkert
Journal:  Nervenarzt       Date:  1985-01       Impact factor: 1.214

4.  TRH-induced TSH response in unipolar, bipolar, and secondary depressions: possible utility in clinical assessment and differential diagnosis.

Authors:  M S Gold; A L Pottash; N Ryan; D R Sweeney; R K Davies; D M Martin
Journal:  Psychoneuroendocrinology       Date:  1980       Impact factor: 4.905

5.  Repetitive intravenous TRH-stimulations at short intervals in euthyroid and hypothyroid subjects.

Authors:  S Ahuja; S Baumgarten; K Oeff
Journal:  Acta Endocrinol (Copenh)       Date:  1980-01

6.  Emotional disturbance and cognitive deficits in hyperthyroidism.

Authors:  D J MacCrimmon; J E Wallace; W M Goldberg; D L Streiner
Journal:  Psychosom Med       Date:  1979-06       Impact factor: 4.312

7.  Using the protirelin test to distinguish mania from schizophrenia.

Authors:  I Extein; A L Pottash; M S Gold; R W Cowdry
Journal:  Arch Gen Psychiatry       Date:  1982-01

8.  Neurotensin-induced hypothermia: evidence for an interaction with dopaminergic systems and the hypothalamic--pituitary--thyroid axis.

Authors:  C B Nemeroff; G Bissette; P J Manberg; A J Osbahr; G R Breese; A J Prange
Journal:  Brain Res       Date:  1980-08-11       Impact factor: 3.252

9.  [Increase of circulating thyroid hormones following oral administration of TRH in preclinical hyperthyroidism. Biological efficacy of minimal TSH stimulation].

Authors:  E Gemsenjäger; J Girard; J J Staub
Journal:  Schweiz Med Wochenschr       Date:  1983-04-02

10.  Thyrotropin releasing hormone (TRH): a useful tool for psychoneuroendocrine investigation.

Authors:  P T Loosen; A J Prange
Journal:  Psychoneuroendocrinology       Date:  1980-01       Impact factor: 4.905

View more
  8 in total

1.  [The role of TSH psychological and somatic changes in thyroid dysfunctions].

Authors:  B Nowotny; J Teuber; W an der Heiden; B Schlote; D Kleinböhl; R Schmidt; S Kaumeier; K H Usadel
Journal:  Klin Wochenschr       Date:  1990-10-03

Review 2.  Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.

Authors:  Robertas Bunevicius; Arthur J Prange
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

3.  Circadian and pulsatile levels of human thyroid-stimulating hormone (TSH) in various stages of hyperthyroidism.

Authors:  I Vardarli; I Vardarli; J Teuber; B Schlote-Sautter; U Schwedes; R Schmidt; U Feldmann; K H Usadel
Journal:  Klin Wochenschr       Date:  1988-10-17

4.  Significance of latent hyperthyroidism.

Authors:  I Vardarli; I Vardarli; R Schmidt; R Paschke; L Schaaf; B Scholte-Sautter; J Teuber; U Feldmann; K H Usadel
Journal:  Klin Wochenschr       Date:  1989-05-15

5.  Health status, mood, and cognition in experimentally induced subclinical thyrotoxicosis.

Authors:  M H Samuels; K G Schuff; N E Carlson; P Carello; J S Janowsky
Journal:  J Clin Endocrinol Metab       Date:  2008-02-19       Impact factor: 5.958

6.  Subclinical hyperthyroidism: physical and mental state of patients.

Authors:  B Schlote; B Nowotny; L Schaaf; D Kleinböhl; R Schmidt; J Teuber; R Paschke; I Vardarli; S Kaumeier; K H Usadel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

7.  Psychopathological and neuropsychological symptoms in patients with subclinical and remitted hyperthyroidism.

Authors:  M Bommer; T Eversmann; R Pickardt; A Leonhardt; D Naber
Journal:  Klin Wochenschr       Date:  1990-06-05

8.  Anxiety and depression are more prevalent in patients with graves' disease than in patients with nodular goitre.

Authors:  Kira Bang Bové; Torquil Watt; Asmus Vogel; Laszlo Hegedüs; Jakob Bue Bjoerner; Mogens Groenvold; Steen Joop Bonnema; Åse Krogh Rasmussen; Ulla Feldt-Rasmussen
Journal:  Eur Thyroid J       Date:  2014-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.